Can-Fite BioPharma CANF
NYSE CANF
$1.59 -0.07 (-4.14%)
As of: Nov 11, 2026 · 12:09 PM EST

Can-Fite BioPharma (CANF) Change in Account Payables (2012 - 2013)

Updated

Can-Fite BioPharma's Change in Account Payables came in at $543,000 for FY2025, up 184.3% from $191,000 in FY2024.

Analysis

Can-Fite BioPharma (CANF) Change in Account Payables (2012 - 2013) Analysis & Trends

Going back to FY2011, Can-Fite BioPharma's Change in Account Payables data covers 15 years.

  • The FY2025 figure represents the highest annual Change in Account Payables since FY2021.
  • Per Business Quant, earlier years put Change in Account Payables at $191,000 in FY2024, -$469,000 in FY2023, -$130,000 in FY2022 and $574,000 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Payables (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 83.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 254.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Can-Fite BioPharma 2.16 Mn -17.54 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2013 359,422.08
Sep 30, 2013 -237,335.28
Jun 30, 2013 -404,644.56
Dec 31, 2012 249,190.67
Sep 30, 2012 48,797.59
Jun 30, 2012 -178,684.20
API Access

Can-Fite BioPharma Change in Account Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-account-payables&ticker=CANF&period=max&api_key=YOUR_API_KEY